GlassScriptPhysician profile
Kevin Tabije
NPI 1164710463
$1,528.74
in general payments reported to CMS, 2019-2025
12 companies · $131 in 2025
The $131 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $45.49 · 2020: $80.66 · 2021: $144 · 2022: $36.55 · 2023: $881 · 2024: $210 · 2025: $131.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $917 · Travel and Lodging: $305.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $916.62 |
| Travel and Lodging | $305.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Curonix LLC | $464.98 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Nevro Corp. | $314.11 | 2019-2024 | Senza |
| Vertos Medical, INC. | $217.69 | 2023-2024 | Mild Device Kit |
| Horizon Therapeutics Plc | $188.20 | 2020-2021 | |
| Mml US, INC. | $73.11 | 2023 | Reactiv8 |
| Boston Scientific Corporation | $70.65 | 2024-2025 | Intracept |
| Medtronic, INC. | $56.21 | 2023 | Intellis Adaptivestim |
| Stryker Corporation | $40.62 | 2025 | Mild Device Kit |
| Avanos Medical | $36.55 | 2022 | |
| Hydrocision, INC. | $27.11 | 2025 | Tenjet |
| Nalu Medical, INC. | $21.11 | 2024 | Nalu Neurostimulation System |
| Spinal Simplicity, LLC | $18.40 | 2025 | Ha Minuteman G3-R |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Tabije listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.